Study on HPV vaccine education in middle schools
Part of Infections clinical trials.
This trial tests if an educational program called e-Bug can increase HPV vaccination rates. It uses only anonymous data from schools, so no individual enrollment is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a middle school student in the PACA region of France
- You are part of the school's routine vaccination data collection
- No personal enrollment is required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This study tests whether a special education program based on the transtheoretical model improves nursing students' knowledge about HPV, their health beliefs, and their intentions to get vaccinated. It aims to help students make informed decisions about HPV prevention.
This study looks at how to best offer the HPV vaccine in Cameroon. It interviews key people who help run or know about the program.
This study tests a program to increase HPV vaccination among teens aged 11-17 in public schools. It aims to see if education and support can help more adolescents get the vaccine to prevent HPV-related cancers.
This study tests whether a special education program and one-on-one motivational talks can help women learn more about HPV and decide about the vaccine. If you join, you will attend three sessions that explain HPV in simple terms and support your choices.
This trial tests whether active health education in schools can increase HPV vaccine coverage among students. It may help protect young people from HPV-related cancers.
Hear when a new Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.